SCHEMBL8393108

SCHEMBL8393108

O=C(C=Cc1ccc([N+](=O)[O-])cc1)N1CCOCC1

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.73
▸ L3MBTL1 Q9Y468 2/20 0.73
▸ SMN1; SMN2 Q16637 3/20 0.67
▸ RAB9A P51151 9/20 0.66
▸ NPC1 O15118 8/20 0.66
▸ HPGD P15428 2/20 0.61
▸ POLB P06746 1/20 0.60
▸ GPR183 P32249 1/20 0.59
▸ TDP1 Q9NUW8 1/20 0.58
▸ MAPT P10636 2/20 0.56
▸ KDM4E B2RXH2 2/20 0.56
▸ AKR1C3 P42330 1/20 0.56
▸ LMNA P02545 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ MAOB P27338 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8393112 1.00 ALDH1A1 (0.73) ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL3010777 0.84 ALDH1A1 (0.58) ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL3010773 0.84 ALDH1A1 (0.58) ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL3441762 0.84 ALDH1A1 (1.00) ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL3441759 0.84 ALDH1A1 (1.00) ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL8788355 0.81 ALDH1A1 (0.65) ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL8788351 0.81 ALDH1A1 (0.65) ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL9652216 0.80 RAB9A (0.73) ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL9652221 0.80 RAB9A (0.73) ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1
SCHEMBL4819739 0.80 RAB9A (0.73) ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998399-A Guanidine derivatives useful in therapy as inhibitors of nitric oxide synthetase ASTRA AKTIEBOLAG (SE) 1999-12-07 — — US disclosed
EP-0690851-B1 GUANIDINE DERIVATIVES USEFUL IN THERAPY ASTRA AB (SE) 1999-05-19 — — EP disclosed
US-5885985-A Guanidine derivatives useful in therapy ASTRA AKTIEBOLAG (SE) 1999-03-23 — — US disclosed
EP-0690851-A1 GUANIDINE DERIVATIVES USEFUL IN THERAPY Astra Aktiebolag (SE) 1996-01-10 — — EP disclosed
WO-1994021621-A1 GUANIDINE DERIVATIVES USEFUL IN THERAPY ASTRA AKTIEBOLAG (SE) 1994-09-29 — — WO disclosed
Send feedback